Anpario (LON:ANP) Sets New 1-Year High – Still a Buy?

Anpario plc (LON:ANP)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 460 ($5.67) and last traded at GBX 454.15 ($5.60), with a volume of 67520 shares. The stock had previously closed at GBX 458.89 ($5.66).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group boosted their price target on shares of Anpario from GBX 380 ($4.68) to GBX 500 ($6.16) and gave the stock a “buy” rating in a research note on Tuesday, January 14th.

Anpario Stock Up 0.5 %

The firm has a market cap of £78.55 million, a PE ratio of 2,580.56 and a beta of 0.58. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The firm has a 50 day moving average price of GBX 374.22 and a 200-day moving average price of GBX 327.26.

Insider Buying and Selling

In other Anpario news, insider Karen Prior sold 14,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.68), for a total value of £53,200 ($65,589.94). 30.51% of the stock is owned by insiders.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.